Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.248NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.248NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21305.4South Korea
B.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.182NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.182NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.218NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.218NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.12.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.12.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.79.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.79.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.78NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.78NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used